Discounting for cost benefit analysis involving private investment, but public benefit
Joint Regulators Group (JRG) statement on cost benefit analysis methodology
JRG has published a statement ( PDF 93 Kb) on the methodology used for discounting for cost-benefit analyses (CBAs). These analyses may be used by regulators when considering measures that generate consumer or wider public benefits, while requiring regulated firms to incur some costs. CBAs enable regulators to estimate the value of the overall benefits of a proposed regulatory intervention.
The JRG brings together various UK regulators to discuss issues of mutual concern and to report on recent developments in their own particular sector. The issue of discounting in CBAs is one which many sector regulators face, and therefore it is an area where regulators can benefit from sharing and promoting good regulatory practice.
October 2011 consultation
Date published: 4 October 2011
Start date: 4 October 2011
Closing date: 5 December 2011
This consultation paper outlined the approaches to discounting that could be taken by regulators within the Joint Regulators Group (JRG). The JRG brings together senior colleagues from the various regulators and meets four times a year to discuss issues of mutual concern and to report on recent developments in their own particular sector.
The focus of this paper was on discounting in the particular case of a cost benefit analysis (CBA) where a firm finances the investment, but benefits mainly accrue to consumers and/or the wider public. This paper did not seek to determine whether or not a regulator should be intervening, but rather if the regulator was considering intervening and using a CBA, what the appropriate technical framework for CBA might be.
Last updated: 25 July 2012